EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

The Effect of Trimethoprim on Thiamine Absorption: A Transporter‐Mediated Drug‐Nutrient Interaction

Bianca Vora iD, Anita Wen, Sook Wah Yee iD, Kim Trinh, Mina Azimi, Elizabeth A E Green, Marina Sirota iD, Andrew S Greenberg, John W Newman, Kathleen M Giacomini iD

Clinical Pharmacology & Therapeutics · 2023

DOI: 10.1002/cpt.2932 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Pharmacology & Therapeutics, 2023. Verfasst von Bianca Vora und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California, USA. Hauptthemen laut MEDLINE: Thiamine, Trimethoprim. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDDK NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trimethoprim is predicted to inhibit several thiamine transporters, including the primary thiamine intestinal absorptive transporter, ThTR‐2, and the hepatic and renal organic cation transporters, OCT1, OCT2, and MATEs. To investigate the effect of trimethoprim on thiamine absorption, studies were conducted in cells, mice, and healthy volunteers and supported by use of real‐world data. In a randomized, crossover clinical study, seven healthy volunteers were given a single oral dose of thiamine or thiamine plus trimethoprim, followed by blood sampling. The thiamine area under the curve (AUC) increased with trimethoprim co‐administration ( P value = 0.031). Similar results were seen in mice. Trimethoprim appeared to act on thiamine absorption through inhibition of hepatic OCT1 as evidenced from its ability to modulate levels of isobutyrylcarnitine and propionylcarnitine, OCT1 biomarkers identified from metabolomic analyses. Real‐world data further supported this finding, showing an association between trimethoprim use and higher levels of triglycerides, LDL cholesterol, and total cholesterol, consistent with OCT1 inhibition ( P values: 2.2 × 10 −16 , 5.75 × 10 −7 , and 5.82 × 10 −7 , respectively). These findings suggest that trimethoprim increases plasma levels of thiamine by inhibiting hepatic OCT1. Trimethoprim reduced urinary excretion and clearance of biomarkers for OCT2 and MATEs, consistent with inhibition of renal organic cation transporters. This inhibition did not appear to play a role in the observed increases in thiamine levels. This study highlights the potential for drug‐nutrient interactions involving transporters, in addition to transporters' established role in drug–drug interactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThiamineTrimethoprimAnimalsMiceHumansMembrane Transport ProteinsFood-Drug InteractionsBiomarkersNutrientsCationsOrganic Cation Transport ProteinsOrganic Cation Transporter 2HEK293 Cells

Substanzen

ThiamineTrimethoprimMembrane Transport ProteinsBiomarkersNutrientsCationsOrganic Cation Transport ProteinsOrganic Cation Transporter 2

Autor:innen und Institutionen

  • Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California, USA.
  • Department of Nutrition, University of California Davis, Davis, California, USA.
  • Jean Mayer United States Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Medford, Massachusetts, USA.
  • Bakar Computational Health Sciences Institute, University of California San Francisco, San Francisco, California, USA.
  • West Coast Metabolomics Center, Genome Center, University of California Davis, Davis, California, USA.
  • Western Human Nutrition Research CenterUnited States Department of Agriculture, Agriculture Research Service, Davis, California, USA.

ORCID-Profile: Bianca Vora, Sook Wah Yee, Marina Sirota, Kathleen M Giacomini

Förderung

  • NIDDK NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Vora, B., Wen, A., Yee, S. W., Trinh, K., Azimi, M., Green, E. A. E., Sirota, M., Greenberg, A. S., Newman, J. W., & Giacomini, K. M. (2023). The Effect of Trimethoprim on Thiamine Absorption: A Transporter‐Mediated Drug‐Nutrient Interaction. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.2932

Vancouver

Vora B, Wen A, Yee SW, Trinh K, Azimi M, Green EAE, et al. The Effect of Trimethoprim on Thiamine Absorption: A Transporter‐Mediated Drug‐Nutrient Interaction. Clinical Pharmacology & Therapeutics. 2023. doi:10.1002/cpt.2932

BibTeX
@article{Vora2023,
  author = {Vora, Bianca and Wen, Anita and Yee, Sook Wah and Trinh, Kim and Azimi, Mina and Green, Elizabeth A E and Sirota, Marina and Greenberg, Andrew S and Newman, John W and Giacomini, Kathleen M},
  title = {The Effect of Trimethoprim on Thiamine Absorption: A Transporter‐Mediated Drug‐Nutrient Interaction},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2023},
  doi = {10.1002/cpt.2932}
}
Kostenlos starten →